目次
Chapter- 1: Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
What's New in This Update?
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table Summary : Global Market for Antibody Drugs, by Antibody Type, Through 2026
Figure Summary : Global Market for Antibody Drugs, by Antibody Type, 2019-2026
Chapter- 3: Market and Technology Background
Antibodies and Antigens
Antibody Functions
Monoclonal Antibodies
Chapter- 4: Market Dynamics
Technical Issues and HAMA Problem
Market Drivers
Market Challenges
Impact of COVID-19 on Antibody Drugs Market
Chapter- 5: Market Breakdown by Technology Type
Market by Type
Market by Region
Market by Manufacturing Process
Chapter- 6: Market Breakdown by Application
Market by Diseases
Chapter- 7: Regulatory Aspects
New Approvals of Monoclonal Antibodies
Recalls and Safety Alerts
Chapter- 8: Patent Review/ New Developments
New Developments
Clinical Trial Phases
Chapter- 9: Competitive Landscape
Mergers and Acquisitions
Antibody Drugs
Chapter- 10: Company Profiles
ABBVIE INC.
AMGEN INC.
ALEXION PHARMACEUTICALS
ASTRAZENECA PHARMACEUTICALS
BIOGEN
BRISTOL-MYERS SQUIBB CO
ELI LILLY
F. HOFFMANN-LA ROCHE AG
FRESENIUS KABI
GLAXOSMITHKLINE
GENMAB A/S
GILEAD SCIENCES INC.
JOHNSON & JOHNSON
MERCK & CO. INC.
MERCK KGAA
NOVARTIS AG
PFIZER INC.
REGENERON PHARMACEUTICALS
SANOFI S.A.
SEAGEN
TAKEDA PHARMACEUTICAL CO., LTD.
UCB CO.
